To test if direct BCR activation leads to upregulation of APOBEC3 genes in CLL cells, we treated the primary CLL cells derived from four different CLL patients with CpG or IgM and measured the expression of the APOBEC3 genes by RT-PCR. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.